NCT05184400 Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer
| NCT ID | NCT05184400 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Herlev and Gentofte Hospital |
| Condition | Biliary Tract Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2015-01-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2015-01-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
No validated biomarkers exist that can identify patients with biliary tract cancer at an early stage or predict treatment outcomes. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.
Eligibility Criteria
Inclusion Criteria: * Histological or cytological diagnosis of BTC * Patients referred for treatment of BTC * Signed informed consent Exclusion Criteria: * None
Frequently Asked Questions
Who can join the NCT05184400 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Biliary Tract Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05184400 currently recruiting?
Yes, NCT05184400 is actively recruiting participants. Visit ClinicalTrials.gov or contact Herlev and Gentofte Hospital to inquire about joining.
Where is the NCT05184400 trial being conducted?
This trial is being conducted at Herlev, Denmark.
Who is sponsoring the NCT05184400 clinical trial?
NCT05184400 is sponsored by Herlev and Gentofte Hospital. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.